Ligand-Independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1

Molecular Cell

Volumn 3, Issue 4, 1999, Pages 513-519

  Tremblay, André ^a   Tremblay, Gilles B ^a   Labrie, Fernand ^b   Giguère, Vincent ^a,c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; STEROID RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; GENE ACTIVATION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

EID: 0033120030     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80479-7     Document Type: Article

References (32)

1. Adams, M., Reginato, M.J., Shao, D., Lazar, M.A., and Chatterjee, V.K. (1997). Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272, 5128- 5132.
2. Aronica, S.M., and Katzenellenbogen, B.S. (1993). Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol. Endocrinol. 7, 743-752.
3. Berry, M., Metzger, D., and Chambon, P. (1990). Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9, 2811-2818.
4. Bunone, G., Briand, P.-A., Miksicek, R.J., and Picard, D. (1996). Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183.
5. Camp, H.S., and Tafuri, S.R. (1997). Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J. Biol. Chem. 272, 10811-10816.
6. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montminy, M.R., and Goodman, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859.
7. Glass, C.K., Rose, D.W., and Rosenfeld, M.G. (1997). Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9, 222-232.
8. Green, S., Walter, P., Kumar, V., Krust, A., Bornet, J.M., Argos, P., and Chambon, P. (1986). Human oestrogen receptor cDNA: Sequence, expression and homology to v-erbA. Nature 320, 134-139.
9. Greene, G.L., Gilna, P., Waterfield, M., Baker, A., Hort, Y., and Shine, J. (1986). Sequence and expression of human estrogen receptor complementary DNA. Science 231, 1150-1154.
10. Hammer, G.D., Krylova, I., Zhang, Y., Darimont, B.D., Simpson, K., Weigel, N.L., and Ingraham, H.A. (1999). Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: Integration of hormone signaling in reproduction and stress. Mol. Cell 3, this issue, 521-526.
11. Henttu, P.M., Kalkhoven, E., and Parker, M.G. (1997). AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol. Cell. Biol. 17, 1832-1839.
12. Hu, E., Kim, J.B., Sarraf, P., and Spiegelman, B.M. (1996). Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274, 2100-2103.
13. Jeyakumar, M., Tanen, M.R., and Bagchi, M.K. (1997). Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Mol. Endocrinol. 11, 755-767.
14. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995). Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
15. Krstic, M.D., Rogatsky, I., Yamamoto, K.R., and Garabedian, M.J. (1997). Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3947-3954.
16. Kuiper, G.G.J.M., Enmark, E., Pelto-Huikko, M., Nilsson, S., and Gustafsson, J.-Å. (1996). Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930.
17. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J.R., and Chambon, P. (1987). Functional domains of the human estrogen receptor. Cell 51, 941-951.
18. Lavinsky, R.M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.M., Schiff, R., Del-Rio, A.L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998). Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl. Acad. Sci. USA 95, 2920-2925.
19. Metzger, D., Ali, S., Bornert, J.M., and Chambon, P. (1995). Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J. Biol. Chem. 270, 9535-9542.
20. Mosselman, S., Polman, J., and Dijkema, R. (1996). ERβ: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 392, 49-53.
21. Oñate, S.A., Tsai, S.Y., Tsai, M.-J., and O'Malley, B.W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
22. Oñate, S.A., Boonyaratanakornkit, V., Spencer, T.E., Tsai, S.Y., Tsai, M.J., Edwards, D.P., and O'Malley, B.W. (1998). The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 273, 12101- 12108.
23. Parker, D., Jhala, U.S., Radhakrishnan, I., Yaffe, M.B., Reyes, C., Schulman, A.I., Cantley, L.C., Wright, P.E., and Montminy, M. (1998). Analysis of an activator-coactivator complex reveals an essential role for secondary structure in transcriptional activation. Mol. Cell 2, 353-359.
24. Rochette-Egly, C., Adam, S., Rossignol, M., Egly, J.-M., and Chambon, P. (1997). Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90, 97-107.
25. Shao, D., Rangwala, S.M., Bailey, ST., Krakow, S.L., Reginato, M.J., and Lazar, M.A. (1998). Interdomain communication regulating ligand binding by PPAR-γ. Nature 396, 377-380.
26. Takeshita, A., Yen, P.M., Misiti, S., Cardona, G.R., Liu, Y., and Chin, W.W. (1996). Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 137, 3594-3597.
27. Taneja, R., Rochette-Egly, C., Plassat, J.-L., Penna, L., Gaub, M.-P., and Chambon, P. (1997). Phosphorylation of activation functions AF-1 and AF-2 of RARα and RARγ is indispensable for differentiation of F9 cells upon retinoic acid and camp treatment. EMBO J. 16, 6452-6465.
28. Tremblay, G.B., Tremblay, A., Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Labrie, F., and Giguère, V. (1997). Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β. Mol. Endocrinol. 11, 353-365.
29. Tremblay, A., Tremblay, G.B., Labrie, C., Labrie, F., and Giguère, V. (1998). EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors α and β. Endocrinology 139, 111-118.
30. Webb, P., Nguyen, P., Shinsako, J., Anderson, C., Feng, W., Nguyen, M.P., Chen, D., Huang, S.-M., Subramanian, S., Mclnerney, E.M., et al. (1998). Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol. Endocrinol. 12, 1605-1618.
31. Weigel, N.L., and Zhang, Y. (1998). Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76, 469-479.
32. Zhang, Y., Beck, C.A., Poletti, A., Clement IV, J.P., Prendergast, P., Yip, T.-T., Hutchens, T.W., Edwards, D.P., and Weigel, N.L. (1997). Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. Mol. Endocrinol. 11, 823-832.